Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Business Insights | Valuing Pharmaceutical Innovation: Pricing and reimbursement for innovative therapies

Valuing Pharmaceutical Innovation: Pricing and reimbursement for innovative therapies

Developing, manufacturing and marketing innovative new pharmaceutical drugs is highly complex and involves significant investment. Establishing an acceptable return on investment requires generating sufficient sales revenues which in turn requires maximizing market access at the highest possible price.

"Pricing and reimbursement strategies for innovative new drugs require significant evidence of beneficial clinical and economic outcomes using cost effectiveness and budget impact models..."

Developing, manufacturing and marketing innovative

New pharmaceutical drugs is highly complex and involves significant investment. Market access must be maximized at the highest possible price to generate sufficient sales revenue an acceptable return on investment. However, limited payor budgets and increased competition from other therapies has increased downward pressure on drug prices across the pharma industry.

'Valuing Pharmaceutical Innovation' is a new report published by Business Insights that explores the latest issues and developments surrounding innovative therapy reimbursement. The main supply and demand side factors influencing pricing, market access and reimbursement decisions across a number of major markets are closely examined and the key trends and economic requirements of major therapeutic categories are assessed. This report also identifies the most successful pricing and market access strategies across each category of innovation with a detailed case study analysis of the pricing challenges encountered by both recently launched innovative therapies and those in late stage development.

Use this report’s case study analysis to benchmark the pricing strategies of leading innovative products and evaluate the reimbursement environments of major markets and therapeutic categories...

Use this new report as a platform to:

• Enhance your market access strategies for upcoming products by comparing the regulatory mechanisms influencing reimbursement decisions across countries including Japan, France, Germany, Italy, Spain, the US and the UK.

• Understand the latest challenges and issues facing various

categories of innovation including ‘new market’, ‘redefining the category’, ‘second-generation’, ‘incremental therapeutic’ and ‘incremental formulation’ innovations.

• Assess the innovative drug reimbursement environments of major therapeutic areas by identifying the current trends, unmet medical need and economic requirements of a range of disease categories including oncology, HIV, autoimmune diseases and diabetes.

• Leverage innovative new market access programs to protect prices for novel therapies in cost constrained reimbursement settings.

• Benchmark the reimbursement strategies of leading products by using detailed case studies of recently launched and upcoming innovative therapies across each type of innovative category.

Jul-08 Format: PDF Pages 121
Table of Contents
Price: $3,835.00 / €2,565.62

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions